Literature DB >> 15479621

Molecular cloning, sequencing, and expression of a fibrinolytic serine-protease gene from the earthworm Lumbricus rubellus.

Il Hwan Cho1, Eui Sung Choi, Hyung Hoan Lee.   

Abstract

The full-length cDNA of the lumbrokinase fraction 6 (F6) protease gene of Lumbricus rubellus was amplified using an mRNA template, sequenced and expressed in E. coli cells. The F6 protease gene consisted of pro- and mature sequences by gene sequence analysis, and the protease was translated and modified into active mature polypeptide by N-terminal amino acid sequence analysis of the F6 protease. The pro-region of F6 protease consisted of the 44 residues from methionine-1 to lysine-44, and the mature polypeptide sequence (239 amino acid residues and one stop codon; 720 bp) started from isoleucine-45 and continued to the terminal residue. F6 protease gene clones having pro-mature sequence and mature sequence produced inclusion bodies in E. coli cells. When inclusion bodies were orally administrated rats, generated thrombus weight in the rat's venous was reduced by approximately 60 % versus controls. When the inclusion bodies were solubilized in pepsin and/or trypsin solutions, the solubilized enzymes showed hemolytic activity in vitro. It was concluded the F6 protease has hemolytic activity, and that it is composed of pro- and mature regions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15479621     DOI: 10.5483/bmbrep.2004.37.5.574

Source DB:  PubMed          Journal:  J Biochem Mol Biol        ISSN: 1225-8687


  3 in total

1.  Purification and characterization of novel fibrinolytic proteases as potential antithrombotic agents from earthworm Perionyx excavatus.

Authors:  Tram Thi Bich Phan; Tien Duy Ta; Dung Thi Xuan Nguyen; Lambertus Am Van Den Broek; Giang Thi Huong Duong
Journal:  AMB Express       Date:  2011-09-30       Impact factor: 3.298

Review 2.  Recombinant protein production of earthworm lumbrokinase for potential antithrombotic application.

Authors:  Kevin Yueju Wang; Lauren Tull; Edwin Cooper; Nan Wang; Dehu Liu
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-12       Impact factor: 2.629

Review 3.  The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications.

Authors:  Douglas B Kell; Etheresia Pretorius
Journal:  Biochem J       Date:  2022-08-31       Impact factor: 3.766

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.